Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to establish the bioequivalence between rivaroxaban tablet
10mg and rivaroxaban granule formulation 10mg, and to assess the safety and tolerability of
rivaroxaban 10mg in healthy adult male subjects.